Skip to content

Nerve block by ropivacaine combined with ketamine for the postoperative analgesia in knee ACLR

NMDA antagonist for postoperative analgesia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023867
Enrollment
Unknown
Registered
2019-06-15
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee ACL reconstruction

Interventions

0.375% ropivacaine:0.375% ropivacaine
ropivacaine plus ketamine:0.375% ropivacaine plus ketamine
ropivacaine plus i.v. ketamine:0.375%ropivacaine plus i.v. ketamine

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 25 to 45 years; 2. ASA I~II level; 3. BMI 20~26kg/m2; 4. Patients undergoing elective knee ACL reconstruction.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating woman; 2. History of allergy to local anesthetics; 3. Mental and neurological diseases; 4. Diabetes and peripheral neuropathy or injury; 5. Patients with systemic diseases such as severe liver and kidney, heart and lung; 6. History of chronic pain; 7. Recent use of painkillers, hormones, and drug abuse history.

Design outcomes

Primary

MeasureTime frame
postoperative NRS pain score;AUC of NRS values;

Secondary

MeasureTime frame
postoperative rescue analgesia time;satisfactory score;sleep at 1st night;rebound pain score;rescue analgesics;

Countries

China

Contacts

Public ContactJiehao Sun

Department of anesthesiology, the First Affiliated Hospital of Wenzhou Medical University

sun_jiehao@126.com+86 13676721930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026